Roche Holding AG (RHHBY)
30.05
-0.03
(-0.10%)
USD |
OTCM |
Apr 18, 16:00
Roche Cash from Investing (TTM): -12.00B for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -12.00B |
| June 30, 2023 | -5.457B |
| December 31, 2022 | -3.044B |
| June 30, 2022 | -5.279B |
| December 31, 2021 | -7.107B |
| June 30, 2021 | -9.103B |
| December 31, 2020 | -9.977B |
| June 30, 2020 | -8.025B |
| December 31, 2019 | -8.703B |
| June 30, 2019 | -7.415B |
| December 31, 2018 | -7.239B |
| June 30, 2018 | -7.236B |
| December 31, 2017 | -6.542B |
| June 30, 2017 | -4.734B |
| December 31, 2016 | -4.522B |
| June 30, 2016 | -5.438B |
| December 31, 2015 | -4.277B |
| June 30, 2015 | -11.89B |
| Date | Value |
|---|---|
| December 31, 2014 | -12.43B |
| June 30, 2014 | -6.043B |
| December 31, 2013 | -1.642B |
| June 30, 2013 | -1.619B |
| December 31, 2012 | -4.854B |
| June 30, 2012 | -1.439B |
| December 31, 2011 | -265.03M |
| June 30, 2011 | -2.312B |
| December 31, 2010 | 2.604B |
| June 30, 2010 | 5.325B |
| December 31, 2009 | -2.943B |
| June 30, 2009 | -5.475B |
| December 31, 2008 | -1.104B |
| June 30, 2008 | -2.009B |
| December 31, 2007 | -5.085B |
| June 30, 2007 | -4.366B |
| December 31, 2006 | -6.027B |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-12.00B
Minimum
Dec 2023
-3.044B
Maximum
Dec 2022
-7.611B
Average
-7.720B
Median
Cash from Investing (TTM) Benchmarks
| Novartis AG | 5.596B |
| Pfizer Inc | -32.28B |
| Eli Lilly and Co | -7.153B |
| ADC Therapeutics SA | -3.216M |
| AC Immune SA | 73.11M |